PAVmed Inc. - Common Stock, Par Value $0.001 Per Share (PAVM)
CUSIP: 70387R403
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock, Par Value $0.001 Per Share
- Shares outstanding
- 6,658,240
- Total 13F shares
- 1,041,798
- Share change
- -78,931
- Total reported value
- $653,834
- Price per share
- $0.63
- Number of holders
- 25
- Value change
- -$49,628
- Number of buys
- 8
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 70387R403?
CUSIP 70387R403 identifies PAVM - PAVmed Inc. - Common Stock, Par Value $0.001 Per Share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 70387R403:
Top shareholders of PAVM - PAVmed Inc. - Common Stock, Par Value $0.001 Per Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
9%
|
600,000
|
$738,000 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
281,015
|
$345,648 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
82,496
|
$101,489 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.1%
|
74,912
|
$92,142 | — | 30 Sep 2024 | |
| James L. Cox |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Joan B. Harvey |
3/4/5
|
Director |
—
class O/S missing
|
65,000
|
$40,508 | — | 22 Feb 2024 | |
| Obermeyer Wealth Partners |
13F
|
Company |
0.32%
|
21,500
|
$26,445 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.31%
|
20,854
|
$25,650 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
11,706
|
$14,398 | — | 30 Sep 2024 | |
| XML Financial, LLC |
13F
|
Company |
0.15%
|
10,067
|
$12,382 | — | 30 Sep 2024 | |
| CWM, LLC |
13F
|
Company |
0.07%
|
4,672
|
$6,000 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
4,834
|
$5,946 | — | 30 Sep 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.06%
|
3,712
|
$4,566 | — | 30 Sep 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.04%
|
2,785
|
$3,425 | — | 30 Sep 2024 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0.01%
|
836
|
$1,028 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
42,692
|
$918 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
mixed-class rows
|
658
mixed-class rows
|
$689 | — | 30 Sep 2024 | |
| Allworth Financial LP |
13F
|
Company |
0.01%
|
447
|
$550 | — | 30 Sep 2024 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
8,466
mixed-class rows
|
$189 | — | 30 Sep 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
116
|
$142 | — | 30 Sep 2024 | |
| Parallel Advisors, LLC |
13F
|
Company |
0%
|
78
|
$96 | — | 30 Sep 2024 | |
| M&R CAPITAL MANAGEMENT INC |
13F
|
Company |
0%
|
67
|
$82 | — | 30 Sep 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
20
|
$24 | — | 30 Sep 2024 | |
| THOMPSON INVESTMENT MANAGEMENT, INC. |
13F
|
Company |
0%
|
4
|
$5 | — | 30 Sep 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Sep 2024 | |
| Brian J. DeGuzman |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
50,000
|
— | — | 18 Feb 2022 |
Institutional Holders of PAVmed Inc. - Common Stock, Par Value $0.001 Per Share (PAVM) as of Q4 2024
As of 31 Dec 2024,
PAVmed Inc. - Common Stock, Par Value $0.001 Per Share (PAVM) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,041,798 shares.
The largest 10 holders included
FIRST MANHATTAN CO. LLC., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., Obermeyer Wealth Partners, STATE STREET CORP, UBS Group AG, NORTHERN TRUST CORP, EXENCIAL WEALTH ADVISORS, LLC, and XML Financial, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
22
Q4 2024 holders
25
Holder diff
3
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.